GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Hologic, Inc. (HOLX) [hlAlert]

Rating:
Neutral HOLX

Hologic, Inc. (HOLX) rated Neutral by Citigroup

Posted on: Wednesday,  Oct 16, 2013  8:25 AM ET by Citigroup

Citigroup rated Neutral Hologic, Inc. (NASDAQ: HOLX) on 10/16/2013. Previously Citigroup rated Buy Hologic, Inc. (NASDAQ: HOLX) on 01/11/2008., when
the stock price was $17.59. Since then, Hologic, Inc. has lost 19.10% as of 08/04/2009's recent price of $14.23.
If you would have followed the previous Citigroup's recommendation on HOLX, you would have lost 19.1% of your investment in 571 days.

Hologic Inc. is a leading supplier of high quality, innovative and clinically valuable diagnostic systems and tests. The company develops, manufactures and markets X-ray bone densitometers and ultrasound bone analyzers that address a growing market for osteoporosis prevention and treatment -- a key element of women's health care. The systems are used by more leading medical schools, universities and osteoporosis opinion leaders than any other bone densitometer.

Citi Investment Research is a highly respected research unit and is comprised of 390 research analysts across 22 countries. Citi Investment Research covers 3,100 companies, representing 90 percent of the market capitalization of the major global indices, and provides macro and quantitative analysis of global markets and sector trends. Combined with Citi's exceptional sales and trading capabilities and Smith Barney's financial consultants, the core focus of the group is to help investing clients make informed decisions by providing value-added, independent, insightful analysis.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/16/2013 8:25 AM Hold
None
21.98
as of 12/13/2013
1 Week   
1 Month   
3 Months   
1 YTD   
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/4/2009 8:25 AM Hold
None
14.23
1/11/2008 8:25 AM Buy
None
17.59 20.25

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy